Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
JCO Oncol Pract ; 18(3): 224-231, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-34905405

RESUMO

Adolescents and young adults (AYAs; age 15-39 years) with cancer are under-represented in cancer clinical trials because of patient, provider, and institutional barriers. Health care technology is increasingly available to and highly used among AYAs and has the potential to improve cancer care delivery. The COVID-19 pandemic forced institutions to rapidly adopt novel approaches for enrollment and monitoring of patients on cancer clinical trials, many of which have the potential for improving AYA trial participation overall. This consensus statement from the Children's Oncology Group AYA Oncology Discipline Committee reviews opportunities to use technology to optimize AYA trial enrollment and study conduct, as well as considerations for widespread implementation of these practices. The use of remote patient eligibility screening, electronic informed consent, virtual tumor boards, remote study visits, and remote patient monitoring are recommended to increase AYA access to trials and decrease the burden of participation. Widespread adoption of these strategies will require new policies focusing on reimbursement for telehealth, license portability, facile communication between electronic health record systems and advanced safeguards to maintain patient privacy and security. Studies are needed to determine optimal approaches to further incorporate technology at every stage of the clinical trial process, from enrollment through study completion.


Assuntos
COVID-19 , Neoplasias , Adolescente , Adulto , COVID-19/epidemiologia , Criança , Comunicação , Humanos , Neoplasias/terapia , Pandemias , SARS-CoV-2 , Tecnologia , Adulto Jovem
2.
Mol Cancer ; 15(1): 42, 2016 05 26.
Artigo em Inglês | MEDLINE | ID: mdl-27231010

RESUMO

MicroRNAs (miRNAs) are emerging as central players in shaping the biology of the Tumor Microenvironment (TME). They do so both by modulating their expression levels within the different cells of the TME and by being shuttled among different cell populations within exosomes and other extracellular vesicles. This review focuses on the state-of-the-art knowledge of the role of miRNAs in the complexity of the TME and highlights limitations and challenges in the field. A better understanding of the mechanisms of action of these fascinating micro molecules will lead to the development of new therapeutic weapons and most importantly, to an improvement in the clinical outcome of cancer patients.


Assuntos
MicroRNAs/genética , Neoplasias/genética , Neoplasias/patologia , Microambiente Tumoral/genética , Animais , Transição Epitelial-Mesenquimal/genética , Exossomos/metabolismo , Humanos , Sistema Imunitário/imunologia , Sistema Imunitário/metabolismo , MicroRNAs/metabolismo , Neoplasias/imunologia , Neoplasias/metabolismo , Neovascularização Patológica/genética , Neovascularização Patológica/metabolismo , Transporte de RNA , Células Estromais/metabolismo , Células Estromais/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...